marijuana stock news

Verde Science, Inc. (VRCI)

 

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue –   –   –   –  
Cost of Revenue
Gross Profit –   –   –   –  
Operating Expenses
Research Development
Selling General and Administrative (31) 253 744 930
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss 31   (253) (744) (930)
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes (84) (372) (753) (938)
Interest Expense
Income Before Tax (84) (372) (753) (938)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (84) (372) (753) (938)
Non-recurring Events
Discontinued Operations (465)
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (84) (372) (1,218) (938)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (84) (372) (1,218) (938)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Plandai Biotechnology Inc. (PLPL) Phytofare® Green Tea Catechins as a Phytogenic Substance in Poultry Diets

Plandai Biotechnology’s Phytofare® Green Tea Catechins as a Phytogenic Substance in Poultry…

4Front Ventures Corp. (FFNT) (FFNTF) to open for adult-use sales at its Chicago dispensary

4Front to open for adult-use sales at its Chicago dispensary  4Front Ventures…

Aurora Cannabis Inc. (ACB) Reliva Expands Portfolio with New CBD Brand, KG7

Aurora Cannabis’s Reliva Expands Portfolio with New CBD Brand, KG7 Reliva, a…

InMed Pharmaceuticals Inc. (IMLFF) Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D…